Neural tube defects prevalence does not increase after modification of the folic acid fortification program in Chile
dc.catalogador | dfo | |
dc.contributor.author | Pardo, Rosa | |
dc.contributor.author | Vilca, Marcela | |
dc.contributor.author | Villarroel del Pino, Luis A. | |
dc.contributor.author | Davalji, Tahera | |
dc.contributor.author | Obrycki, John F. | |
dc.contributor.author | Mazumdar, Maitreyi | |
dc.contributor.author | Ávila, Claudia | |
dc.contributor.author | Mellado Sagredo, Cecilia | |
dc.date.accessioned | 2024-01-22T16:22:21Z | |
dc.date.available | 2024-01-22T16:22:21Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background:In 2000, Chile’s Ministry of Health mandated fortification ofwheat flour with folic acid at a concentration of 2.2 mg/kg to prevent neuraltube defects (NTDs), resulting in a 50% reduction in NTD prevalence. Con-cerns about possible collateral effects of high folic acid intake led, in 2009, todecrease the folic acid fortification to 1.8 mg/kg of flour. Our study evaluatedthe impact of this modification on the prevalence of NTDs in Santiago.Methods:This study measured the prevalence of NTDs in live births and still-births born in Santiago. We calculated prevalence ratios (PR) and 95% confi-dence intervals (CI) between pre-folic acid fortification (1999–2000), post-folicacid fortification (2001–2009), and post-modified folic acid fortification (2010–2015) periods for all NTDs and their specific types. We used chi-square tests toanalyze proportions, and a Joinpoint regression to visualize prevalence timetrends.Results:The NTD prevalence for the period 2001–2015 was 8.9 per 10,000births, which represents a 48% reduction (PR=0.52; 95% CI=0.45–0.61;p< .001) from the pre-folic acid fortification period. During 2010–2015, theNTD prevalence was 9.5/10,000 births, which was higher, but not statisticallysignificantly different from 2001 to 2009 prevalence of 8.6/10,000 (PR=1.11;95% CI=0.96–1.30,p=.17).Conclusions:Decreasing the concentration of folic acid fortification was notassociated with a statistically significant change in the prevalence of NTDs.Mandatory folic acid fortification continues to be a safe and highly effectivepolicy to prevent NTDs. Future studies should evaluate the prevalence ofNTDs across Chile and adherence to folic acid fortification mandates | |
dc.fechaingreso.objetodigital | 2024-10-29 | |
dc.fuente.origen | ORCID-ene24 | |
dc.identifier.doi | 10.1002/bdr2.1994 | |
dc.identifier.issn | 2472-1727 | |
dc.identifier.uri | https://doi.org/10.1002/bdr2.1994 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/80893 | |
dc.identifier.wosid | WOS:000761250600001 | |
dc.information.autoruc | Escuela de Medicina; Villarroel del Pino, Luis A.; 0000-0001-9603-937X; 77182 | |
dc.information.autoruc | Escuela de Medicina; Mellado Sagredo, Cecilia; 0000-0002-6032-4651; 1002671 | |
dc.issue.numero | 7 | |
dc.language.iso | en | |
dc.nota.acceso | contenido parcial | |
dc.pagina.final | 266 | |
dc.pagina.inicio | 259 | |
dc.revista | Birth Defects Research | |
dc.rights | acceso restringido | |
dc.subject | Chile | |
dc.subject | Folic acid | |
dc.subject | Fortification | |
dc.subject | Neural tube defects | |
dc.subject.ddc | 600 | |
dc.subject.dewey | Tecnología | es_ES |
dc.subject.ods | 03 Good health and well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Neural tube defects prevalence does not increase after modification of the folic acid fortification program in Chile | |
dc.type | artículo | |
dc.volumen | 114 | |
sipa.codpersvinculados | 77182 | |
sipa.codpersvinculados | 1002671 | |
sipa.trazabilidad | WOS;18-03-2022 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Neural tube defects prevalence does not increase after modification of the folic acid fortification program in Chile.pdf
- Size:
- 3.12 KB
- Format:
- Adobe Portable Document Format
- Description: